Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree Bethesdan

Sep 23, 2019 7:00 AM - Sep 24, 2019 5:00 PM

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Biosimilars Conference

Session 3: New Paths To Biosimilar Access: How These Stakeholders Can Promote Uptake

Session Chair(s)

Anna  Welch, MA

Anna Welch, MA

Chief Editor, Biosimilar Development

Life Science Connect, United States

Pharmacy benefits managers, patients, and physicians are credited with having the most influence in terms of U.S. biosimilar market access. While these stakeholders are critical pieces of the puzzle, the employer, health system, and GPO are often overlooked influencers in educating about biosimilars and improving uptake. This session will examine the tools each of these stakeholders have at their disposal to overcome systemic barriers individually and collectively to promote greater biosimilar access.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Recognize the biosimilar education and uptake efforts occurring at the employer, health system, and GPO/payer levels
  • Identify and assess barriers to biosimilar access within the healthcare value chain
  • Evaluate new collaborative strategies to overcome systemic healthcare barriers and improve biosimilar access


Lauren  Vela


Lauren Vela

Pacific Business Group on Health, United States

Senior Director

Ned  Pojskic


Ned Pojskic

Green Shield Canada, Canada

Leader, Pharmacy & Health Provider Relations

Sameer  Awsare, MD


Sameer Awsare, MD

Permanente Medicine, The Permanente Medical Group, United States

FACP Associate Executive Director

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.